Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
Diane V. Havlir(University of California, San Francisco), Ian Sanne(University of the Witwatersrand), E. Moko(Botswana Harvard AIDS Institute Partnership), Mina C. Hosseinipour, Breno Santos(Hospital Nossa Senhora da Conceição), Jean W. Pape(Gheskio Centers), Johnstone Kumwenda(Blantyre Institute for Community Ophthalmology), Susan Swindells(University of Nebraska Medical Center), N. Kumarasamy(YR Gaitonde Centre for AIDS Research and Education), Xingye Wu(University of Chicago Medical Center), Nesri Padayatchi(Centre for the AIDS Programme of Research in South Africa), James F. Rooney(Gilead Sciences (United States)), Fred Sawe(Henry M. Jackson Foundation), Michelle A. Kendall(Harvard University), Evelyn Hogg(Social and Scientific Systems (United States)), Stewart E. Reid(Centre for Infectious Disease Research in Zambia), Peter Mugyenyi(Joint Clinical Research Centre), Umesh Lalloo(Wentworth Hospital), Prudence Ive(Perinatal HIV Research Unit), Anne F. Luetkemeyer(University of California, San Francisco), Lerato Mohapi, Valdiléa G. Veloso, Fatuma Some(Moi University), Jorge Sánchez(Universidad de Antioquia), Alejandro Sanchez(University of Southern California), Janet Andersen(Harvard University), James Hakim(University of Zimbabwe), Javier R. Lama(Asociación Civil Impacta Salud y Educación), Aida Asmelash(Family Health International 360), Sarojini S. Qasba(Montgomery County Department of Health and Human Services)
Cited by 541
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Notch Signaling Augments BMP9-Induced Bone Formation by Promoting the Osteogenesis-Angiogenesis Coupling Process in Mesenchymal Stem Cells (MSCs)
|Cellular Physiology and Biochemistry|2017|2.8k
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
|Science|1997|2.2k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k